Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease

Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine

(2014) Sita Awasthi et al.   JOURNAL OF INFECTIOUS DISEASES

Dissection of the Antibody Response against Herpes Simplex Virus Glycoproteins in Naturally Infected Humans

(2014) T. M. Cairns et al.   JOURNAL OF VIROLOGY

Herpes Simplex Virus Type 2 Glycoprotein H Interacts with Integrin  v 3 To Facilitate Viral Entry and Calcium Signaling in Human Genital Tract Epithelial Cells

(2014) N. Cheshenko et al.   JOURNAL OF VIROLOGY

Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection

(2014) Shalini Sharma et al.   MICROBES AND INFECTION

Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

(2014) David J DiLillo et al.   NATURE MEDICINE

Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1–dependent NK cell-mediated lysis of infected cells

(2014) Korneel Grauwet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression

(2013) Natalia Cheshenko et al.   FASEB JOURNAL

Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women

(2013) R. B. Belshe et al.   JOURNAL OF INFECTIOUS DISEASES

Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread

(2013) B. Nixon et al.   JOURNAL OF VIROLOGY

Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults

(2013) Geert Leroux-Roels et al.   Human Vaccines & Immunotherapeutics

Herpes Simplex Virus-2 Glycoprotein Interaction with HVEM Influences Virus-Specific Recall Cellular Responses at the Mucosa

(2012) Sarah J. Kopp et al.   Clinical & Developmental Immunology

Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women

(2012) David I. Bernstein et al.   CLINICAL INFECTIOUS DISEASES

Dendritic Cell Activation and Memory Cell Development Are Impaired among Mice Administered Medroxyprogesterone Acetate Prior to Mucosal Herpes Simplex Virus Type 1 Infection

(2012) R. D. Vicetti Miguel et al.   JOURNAL OF IMMUNOLOGY

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

(2012) M. Bonsignori et al.   JOURNAL OF VIROLOGY

A vaccine strategy that protects against genital herpes by establishing local memory T cells

(2012) Haina Shin et al.   NATURE

Efficacy Results of a Trial of a Herpes Simplex Vaccine

(2012) Robert B. Belshe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety

(2011) Theodore J. Segarra et al.   PLoS One

Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection

(2011) Z. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques

(2011) Izabela Bialuk et al.   VACCINE

Herpes Simplex Virus Glycoprotein D Interferes with Binding of Herpesvirus Entry Mediator to Its Ligands through Downregulation and Direct Competition

(2010) K. M. Stiles et al.   JOURNAL OF VIROLOGY

Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines

(2009) R. H. Florese et al.   JOURNAL OF IMMUNOLOGY

Protection from Herpes Simplex Virus (HSV)–2 Infection with Replication‐Defective HSV‐2 or Glycoprotein D2 Vaccines in HSV‐1–Seropositive and HSV‐1–Seronegative Guinea Pigs

(2009) Yo Hoshino et al.   JOURNAL OF INFECTIOUS DISEASES

The Virological Synapse Facilitates Herpes Simplex Virus Entry into T Cells

(2009) M. Aubert et al.   JOURNAL OF VIROLOGY

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

(2008) Katharine Looker   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs

(2008) Yo Hoshino et al.   VACCINE

Disruption of the UL41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

(2007) Timothy Dudek et al.   VIROLOGY